Overview
Describe how iPSCs are generated and applied in drug discovery and regenerative medicine., Explain how AI accelerates drug screening, toxicity prediction, and personalized therapy., Evaluate the limitations of traditional drug development and benefits of clinical trials in a dish., Identify how lab-grown organoids and patient-derived cells improve disease modeling.
This course is perfect for biology or medical students, early-career researchers, tech enthusiasts, and anyone curious about the future of drug discovery, AI, and stem cell science.
No prior experience needed. A curiosity for medicine, biotech, or AI is all you need.
Are you curious about how the future of drug discovery is shifting toward patient-specific, human-relevant systems? This course introduces you to the cutting-edge intersection of iPSC technology, AI, and organoids that is redefining biomedical research.
You will learn how induced pluripotent stem cells, or iPSCs, are generated from adult somatic cells using Yamanaka factors, and how they can be differentiated into functional, organ-specific tissues. These lab-grown tissues, known as organoids, are already being used in clinical trials in a dish to predict drug responses with far greater accuracy than animal models.
We will also explore how artificial intelligence is revolutionizing safety assessment, drug screening, and personalized medicine. Key topics include the FDA Modernization Act 2.0, preclinical safety pipelines, biobanking, and case studies in cardiology, oncology, and neurodegenerative disease research.
This course is ideal for students, pre-med learners, biotech professionals, and anyone passionate about the future of translational science. No prior lab experience required — just curiosity and a drive to understand the future of precision medicine.
What you will learn:
iPSC generation, differentiation, and therapeutic applications
Organoid models and their role in preclinical testing
AI-driven approaches in drug development
Ethical, regulatory, and safety frameworks in next-gen therapeutics
Join us and become fluent in the science behind tomorrow's medicine.
Dr. Amogh Gopinathan Nair
Dr. Amogh Gopinathan Nair, Ph.D
Immuno-Oncology & Stem Cell Scientist | Antibody Engineering & AI-Driven Drug Discovery | Regulatory Affairs & Translational Research Expert | 15+ Years in Academia & Industry | Merck-MITACS and Lonza-Trained
Hello everyone, I am Dr. Amogh Nair, a scientist-educator with over 15 years of experience at the intersection of cutting-edge biology and real-world drug development—from discovery to IND-enabling studies, clinical trial design, and early market access. Trained in both academic rigor and industry precision, I specialize in therapeutic antibody engineering, immuno-oncology, stem cell technologies, AI-enhanced drug discovery, and regulatory strategy.
My professional journey has taken me from GMP-driven cell line development at Lonza to CRISPR-edited iPSC models at the University of Sheffield, and from multi-specific antibody development in clinical-stage oncology programs to regulatory interactions with global health authorities.
Areas of Expertise:
Antibody Engineering (hybridoma, bi-specifics, ADCs, CAR-T)
Stem Cells & Organoids (hESCs, iPSCs, CRISPR/TALEN, disease modeling)
Immuno-Oncology (tumor biology, MOA studies, biomarker integration)
AI in Drug Discovery (epitope prediction, HT screening, lead optimization)
Regulatory Affairs (preclinical strategy, IND packages, trial design, market access)
As Your Instructor, I Offer:
Clarity & Context – I break down complex topics into actionable insights for biotech, clinical, and regulatory learners.
Real-World Relevance – Every concept connects to current therapeutics, real drug programs, and actual regulatory decisions.
Career-Ready Knowledge – Whether you are transitioning from academia or upskilling in biotech, I teach with the mindset of industry readiness.
Featured Course Topics:
Antibody Engineering for Oncology and Cardio-metabolic diseases (GLP-1, GIP, GCGR) – structure, function, platforms, clinical relevance
CAR-T & Biologics – core concepts, applications, safety, and scalability
AI & Drug Discovery – predictive tools, pipeline acceleration, integration with wet-lab research
Stem Cell Biology in Medicine – iPSC technologies, Organoids, “clinical trials in a dish” and AI integration.
Regulatory Pathways – how therapeutics move from bench to bedside
Outside the lab, I am a dedicated trail runner and culinary explorer—both of which teach the same lesson I bring into the classroom: exploration, precision, patience, and purpose.
If you are seeking an instructor who brings deep scientific knowledge, cross-functional experience, and a passion for clear, impactful teaching, you are in the right place.
Go ahead, learn the skills and explore.